<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685903</url>
  </required_header>
  <id_info>
    <org_study_id>CLN-CVI-4801</org_study_id>
    <nct_id>NCT03685903</nct_id>
  </id_info>
  <brief_title>Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure.</brief_title>
  <official_title>Prospective Observational Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure in Pancreaticobiliary and Periampullary Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capso Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capso Vision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational Non-Significant Risk (NSR) Study will be used to assess the ability of
      CapsoCam® Plus (SV-3) capsule endoscope to detect the duodenal papilla and visualize
      pathology or abnormalities in the periampullary area and will prospectively compare the
      capsule endoscopy and EUS/ERCP pictorial images acquired in procedures conducted in a minimum
      of 20 and a maximum of 200 research patients.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 26, 2018</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The ability to detect and visualize the duodenal papilla</measure>
    <time_frame>during capsule endoscopy procedure</time_frame>
    <description>Rate of duodenal papilla detection</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Patients Indicated for Periampullary or Pancreaticobiliary Examination</condition>
  <arm_group>
    <arm_group_label>CapsoCam® Plus (SV-3) capsule endoscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscope Capsule</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CapsoCam® Plus (SV-3) capsule endoscope</intervention_name>
    <description>Endoscope Capsule</description>
    <arm_group_label>CapsoCam® Plus (SV-3) capsule endoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females at least 18 years of age.

          -  Provided written HIPAA Informed Consent in the IRB approved language.

          -  Patients indicated for periampullary or pancreaticobiliary examination, with prior
             cross-sectional imaging (CT/MRI/US/other) performed within past 6 months.

        Exclusion Criteria:

          -  Patients with existing biliary stent will be excluded

          -  EUS/ERCP exclusion criteria: per medical practice, including:

               1. Patient refusal to undergo procedure, unstable cardiopulmonary, neurologic, or
                  cardiovascular status; existing bowel perforation

               2. Structural abnormalities of esophagus, stomach, small intestine at the discretion
                  of physician.

          -  Capsule Endoscopy (CE) exclusion criteria:

               1. CE exclusion criteria: difficulty swallowing, pregnancy, known motility issues
                  (gastroparesis), known strictures, gastrointestinal obstructions, fistula or
                  significantly distorted anatomy.

               2. Medical history of receipt of surgery, oncologic therapy, or radiation therapy
                  who, in the opinion of the investigator, are at greater risk of capsule endoscope
                  retention.

               3. Any other contra-indicated condition as noted on the CapsoCam® Plus (SV-3)
                  Instructions for Use, package insert.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

